Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil in the Early Management of Severe Acute Pain in Emergency Departments.

NCT07344350 is registered in ClinicalTrials.gov with Groupe Hospitalier de la Region de Mulhouse et Sud Alsace as lead sponsor.

NCT NCT07344350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07344350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil in the Early Management of Severe Acute Pain in Emergency Departments.
Lead sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Phase
Observational
Overall status
Withdrawn
Start date
January 31, 2026
Completion date
May 1, 2026
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute pain